Four patients had their RAI treatment dosage adjusted due to regional lymph node metastases coupled with higher ps-Tg levels: two cases increased from 100 to 125 mCi, and the other two from 125 to 150 mCi. This evidence concerns the gene TG and metastatic malignant neoplasm in the lymph nodes.